HSE Safety Alert To The Printing Industry: Fatalities On Hand-Fed Platen Machines, UK The
Health and Safety Executive (HSE) has issued a safety alert aimed at employers in the printing industry who use hand-fed platen machines. This follows two fatal incidents in the last 13 months where machine operators have been crushed between the platens. In both cases the machines were being operated in 'dwell' mode at the time of the intervention.
Source: www.medicalnewstoday.comMerck Wins Appeal Of First VIOXX(R) Case To Go To Trial Merck & Co., Inc. said that it is gratified that a Texas appeals court overturned the August 2005 verdict of a state court jury in Brazoria County and rendered a judgment in favor of Merck in the VIOXX product liability case Ernst v. Merck. It was the first VIOXX case to go to trial after the Company voluntarily removed the
medicine from the market.
Source: www.medicalnewstoday.comTarceva(R) Delivers Benefits Across Broad Range Of Non-Small Cell Lung Cancer Patients - Confirmed By New Data New data presented at ASCO 2008 from TRUST1, the largest non-small cell lung cancer (NSCLC) Phase IV trial ever conducted, show that a broad range of NSCLC patients treated with Tarceva (erlotinib) experience clinical benefits including longer survival, better quality of life, control of disease symptoms and control of cancer progression.
Source: www.medicalnewstoday.comMajor Independent Trial Demonstrates Significant Anticancer Benefit Of Zometa(R) In Premenopausal Women With Early-Stage Breast Cancer New data presented today showed that Zometa(R) (zoledronicacid) offered a significant anticancer benefit for premenopausal women withhormone-sensitive, early-stage breast cancer. The study found that Zometawhen added to hormone therapy, following surgery, significantly reduced therisk of cancer returning or death by 36% beyond clinical benefits achievedwith hormone therapy alone.
Source: www.medicalnewstoday.comLabels: No Prescription, Online Pharmacy
# posted by Network @ 4:00 AM
